Literature DB >> 744496

Kinetics of 14C-glycocholic acid clearance in normal man and in patients with liver disease.

I T Gilmore, R P Thompson.   

Abstract

The plasma clearance of a tracer dose of 14C-glycocholic acid, and fasting total serum bile acid concentrations were measured in 14 control subjects and in 38 patients with acute and chronic liver disease. In controls plasma clearance was 415 +/- 24 ml min-1 m-2 (mean +/- SEM), equivalent to a 'first-pass' extraction by the liver of 85%. Clearance was not significantly different from controls in patients with acute hepatitis or active chronic hepatitis, nor in anicteric patients with primary biliary or alcoholic cirrhosis. Thus bile acid clearance was impaired only in icteric chronic liver disease. In contrast, serum bile acid concentrations were abnormal in all but seven patients, six of whom had active chronic hepatitis in complete biochemical remission. The pattern of plasma disappearance of injected 14C-glycocholic acid was biexponential in controls and patients with liver disease, and computer analysis of the curves suggested that there was significant distribution of bile acid outside the vascular space. The preservation of bile acid clearance in anicteric chronic liver disease confirms that it is dependent more on liver blood flow than on liver cell function.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 744496      PMCID: PMC1412319          DOI: 10.1136/gut.19.12.1110

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  17 in total

1.  A simple batch adsorption procedure for the isolation of sulfated and non-sulfated bile acids from serum.

Authors:  G P Van Berge Henegouwen; A F Hofmann
Journal:  Clin Chim Acta       Date:  1976-12       Impact factor: 3.786

2.  Diagnositic value of serum bile acid estimations in liver disease.

Authors:  S Barnes; G A Gallo; D B Trash; J S Morris
Journal:  J Clin Pathol       Date:  1975-06       Impact factor: 3.411

3.  Kinetics of [14C]cholic acid in fulminant hepatic failure: a prognostic test.

Authors:  W Horak; R Waldram; I M Murray-Lyon; E Schuster; R Williams
Journal:  Gastroenterology       Date:  1976-11       Impact factor: 22.682

Review 4.  Drug disposition and liver disease.

Authors:  G R Wilkinson; S Schenker
Journal:  Drug Metab Rev       Date:  1975       Impact factor: 4.518

5.  Assessment of the plasma disappearance of cholyl'l14C-glycine as a test of hepatocellular disease.

Authors:  B Thjodleifsson; S Barnes; A Chitranukroh; B H Billing; S Sherlock
Journal:  Gut       Date:  1977-09       Impact factor: 23.059

Review 6.  The enterohepatic circulation of bile acids in man.

Authors:  A F Hofmann
Journal:  Clin Gastroenterol       Date:  1977-01

7.  Assessment of activity in chronic active liver disease. Serum bile acids compared with conventional tests and histology.

Authors:  M G Korman; A F Hofmann; W H Summerskill
Journal:  N Engl J Med       Date:  1974-06-20       Impact factor: 91.245

8.  Factors affecting plasma clearance of (14C) cholic acid in patients with cirrhosis.

Authors:  M D Kaye; J E Struthers; J S Tidball; E DeNiro; F Kern
Journal:  Clin Sci Mol Med       Date:  1973-08

9.  The influence of conjugation of cholic acid on its uptake and secretion: hepatic extraction of taurocholate and cholate in the dog.

Authors:  E R O'Máille; T G Richards; A H Short
Journal:  J Physiol       Date:  1967-04       Impact factor: 5.182

10.  Dynamics of the enterohepatic circulation of bile acids. Postprandial serum concentrations of conjugates of cholic acid in health, cholecystectomized patients, and patients with bile acid malabsorption.

Authors:  N F LaRusso; M G Korman; N E Hoffman; A F Hofmann
Journal:  N Engl J Med       Date:  1974-10-03       Impact factor: 91.245

View more
  6 in total

1.  Interaction of mixed micelles formed from glycocholic acid and lecithin with the protein binding of various drugs.

Authors:  T W Guentert; S Oie; L Paalzow; B M Frey; R Brandt; L J Aarons; M Rowland
Journal:  Br J Clin Pharmacol       Date:  1987-05       Impact factor: 4.335

2.  Plasma clearance of oral and intravenous cholic acid in subjects with and without chronic liver disease.

Authors:  I T Gilmore; R P Thompson
Journal:  Gut       Date:  1980-02       Impact factor: 23.059

Review 3.  Organic anion uptake by hepatocytes.

Authors:  Allan W Wolkoff
Journal:  Compr Physiol       Date:  2014-10       Impact factor: 9.090

4.  Description and simulation of a physiological pharmacokinetic model for the metabolism and enterohepatic circulation of bile acids in man. Cholic acid in healthy man.

Authors:  A F Hofmann; G Molino; M Milanese; G Belforte
Journal:  J Clin Invest       Date:  1983-04       Impact factor: 14.808

5.  Bile acid clearance in liver disease.

Authors:  L K Luey; K W Heaton
Journal:  Gut       Date:  1979-12       Impact factor: 23.059

6.  Detection of hepatocellular carcinoma in hepatitis C patients: biomarker discovery by LC-MS.

Authors:  Jeremiah Bowers; Emma Hughes; Nicholas Skill; Mary Maluccio; Daniel Raftery
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2014-03-02       Impact factor: 3.205

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.